SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: tom pope who wrote (31565)3/30/2005 8:32:23 AM
From: david nordic  Read Replies (1) | Respond to of 32384
 
Targretin NSCLC did not meet the primary or secondary endpoints. These endpoints were for 1st line. Can the phase III data still generate a 2nd or 3rd line NDA for NSCLC using the same data. Of course the data must show this. Am I missing anything here?